Literature DB >> 9924055

Dilemmas in treating early prostate cancer: the evidence and a questionnaire survey of consultant urologists in the United Kingdom.

J L Donovan1, S J Frankel, A Faulkner, S Selley, D Gillatt, F C Hamdy.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 9924055      PMCID: PMC27712          DOI: 10.1136/bmj.318.7179.299

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  The diagnosis, management, treatment and costs of prostate cancer in England and Wales.

Authors:  J Chamberlain; J Melia; S Moss; J Brown
Journal:  Health Technol Assess       Date:  1997       Impact factor: 4.014

2.  Screening could seriously damage your health.

Authors:  S Stewart-Brown; A Farmer
Journal:  BMJ       Date:  1997-02-22

3.  Should we screen for prostate cancer?

Authors:  S H Woolf
Journal:  BMJ       Date:  1997-04-05

Review 4.  Diagnosis, management and screening of early localised prostate cancer.

Authors:  S Selley; J Donovan; A Faulkner; J Coast; D Gillatt
Journal:  Health Technol Assess       Date:  1997       Impact factor: 4.014

5.  Quality-of-life outcomes in men treated for localized prostate cancer.

Authors:  M S Litwin; R D Hays; A Fink; P A Ganz; B Leake; G E Leach; R H Brook
Journal:  JAMA       Date:  1995-01-11       Impact factor: 56.272

  5 in total
  9 in total

1.  Screening for prostate cancer in the UK. Seems to be creeping in by the back door.

Authors:  J L Donovan; S J Frankel; D E Neal; F C Hamdy
Journal:  BMJ       Date:  2001-10-06

2.  Storm over screening for prostate specific antigen. Right to choose is important.

Authors:  Martin J Duckworth
Journal:  BMJ       Date:  2002-06-08

3.  Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancer.

Authors:  Freddie C Hamdy; Jenny L Donovan; J Athene Lane; David E Neal
Journal:  BMJ       Date:  2003-06-28

4.  What urologists say they do for men with prostate cancer.

Authors:  M Emberton
Journal:  BMJ       Date:  1999-01-30

5.  Presenting treatment options to men with clinically localized prostate cancer: the acceptability of active surveillance/monitoring.

Authors:  Jenny L Donovan
Journal:  J Natl Cancer Inst Monogr       Date:  2012-12

6.  PSA testing: are patients aware of what lies ahead?

Authors:  Marc Lamplugh; Paul Gilmore; Timothy Quinlan; Philip Cornford
Journal:  Ann R Coll Surg Engl       Date:  2006-05       Impact factor: 1.891

7.  Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer.

Authors:  C C Parker; A R Norman; R A Huddart; A Horwich; D P Dearnaley
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

8.  Trends in non-metastatic prostate cancer management in the Northern and Yorkshire region of England, 2000-2006.

Authors:  L Fairley; M Baker; J Whiteway; W Cross; D Forman
Journal:  Br J Cancer       Date:  2009-11-10       Impact factor: 7.640

9.  Planning primary therapy.

Authors:  P Whelan
Journal:  Cancer Imaging       Date:  2000-10-10       Impact factor: 3.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.